# High Dose IMVAMUNE® in Vaccinia-Naive Individuals

> **NCT00879762** · PHASE2 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 91 (actual)

## Conditions studied

- Smallpox

## Interventions

- **BIOLOGICAL:** MVA Smallpox Vaccine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00879762
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-05-29
- **Primary completion:** 2011-03-09
- **Final completion:** 2011-03-09
- **Target enrollment:** 91 (ACTUAL)
- **Last updated:** 2025-06-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00879762

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00879762, "High Dose IMVAMUNE® in Vaccinia-Naive Individuals". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00879762. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*